文献速递心境障碍

抗抑郁药通过诱导受鞘磷脂-神经酰胺调控的自噬发挥作用

Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide.
PubMed 文献 · Mol Psychiatry · 2018-07-23

该研究探讨抗抑郁药分子机制,发现阿米替林和氟西汀通过溶酶体和高尔基膜鞘磷脂及内质网神经酰胺缓慢积累诱导海马神经元自噬。直接抑制鞘磷脂合成酶可快速积累神经酰胺、激活自噬并逆转应激诱导的抑郁样生化和行为改变,而抑制Beclin可阻断抗抑郁效应。

要点

  • 抗抑郁药通过鞘磷脂-神经酰胺通路诱导海马神经元自噬。
  • 直接抑制鞘磷脂合成酶可在3天内快速激活自噬并逆转抑郁样改变。
  • 抑制Beclin可阻断抗抑郁药效应并诱发抑郁样细胞和行为变化。

核心结论

  • 抗抑郁药通过诱导受鞘磷脂-神经酰胺调控的自噬发挥抗抑郁作用。
  • 鞘磷脂-神经酰胺调控的自噬是抗抑郁治疗的重要靶点。

研究设计与样本

  • 基础研究,在海马神经元中探讨阿米替林和氟西汀诱导自噬的分子机制。

主要发现

  • 阿米替林和氟西汀通过溶酶体和高尔基膜鞘磷脂及内质网神经酰胺的缓慢积累诱导海马神经元自噬。
  • 内质网神经酰胺刺激磷酸酶2A,进而激活Ulk、Beclin、Vps34/磷脂酰肌醇3-激酶、p62和Lc3B等自噬蛋白。
  • 阿米替林或氟西汀需至少12天才能实现鞘磷脂积累及后续生化和细胞改变。
  • 用D609直接抑制鞘磷脂合成酶可在3天内导致内质网神经酰胺积累、自噬激活并逆转应激诱导抑郁模型的生化和行为改变。
  • 抑制Beclin可阻断阿米替林和D609的抗抑郁效应,并诱导抑郁症典型的细胞和行为改变。

临床怎么用

  • 提示鞘磷脂-神经酰胺调控的自噬可作为抗抑郁治疗新靶点。
  • 为开发数天内起效的新型抗抑郁药提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Major depressive disorder (MDD) is a common and severe disease characterized by mood changes, somatic alterations, and often suicide. MDD is treated with antidepressants, but the molecular mechanism of their action is unknown. We found that widely used antidepressants such as amitriptyline and fluoxetine induce autophagy in hippocampal neurons via the slow accumulation of sphingomyelin in lysosomes and Golgi membranes and of ceramide in the endoplasmic reticulum (ER). ER ceramide stimulates phosphatase 2A and thereby the autophagy proteins Ulk, Beclin, Vps34/Phosphatidylinositol 3-kinase, p62, and Lc3B. Although treatment with amitriptyline or fluoxetine requires at least 12 days to achieve sphingomyelin accumulation and the subsequent biochemical and cellular changes, direct inhibition of sphingomyelin synthases with tricyclodecan-9-yl-xanthogenate (D609) results in rapid (within 3 days) accumulation of ceramide in the ER, activation of autophagy, and reversal of biochemical and behavioral signs of stress-induced MDD. Inhibition of Beclin blocks the antidepressive effects of amitriptyline and D609 and induces cellular and behavioral changes typical of MDD. These findings identify sphingolipid-controlled autophagy as an important target for antidepressive treatment methods and provide a rationale for the development of novel antidepressants that act within a few days.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Gulbins A, Schumacher F, Becker KA, et al. Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide. Mol Psychiatry. 2018. PMID: 30038230. doi:10.1038/s41380-018-0090-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。